Clinical Trials Logo

Cataract clinical trials

View clinical trials related to Cataract.

Filter by:

NCT ID: NCT00699803 Completed - Cataract Clinical Trials

Study of T-PRED(TM) Compared to Pred Forte(R)

Start date: May 2008
Phase: Phase 2
Study type: Interventional

Study of T-PRED(TM) compared to Pred Forte(R)

NCT ID: NCT00698724 Completed - Cataracts Clinical Trials

Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care

Start date: June 2008
Phase: Phase 4
Study type: Interventional

To compare the efficacy of twice-daily topical bromfenac (Xibrom) ophthalmic solution alone versus twice-daily topical Xibrom with prednisolone acetate 1% three-times daily on visual acuity and OCT measurements.

NCT ID: NCT00690222 Terminated - Cataract Clinical Trials

Intracameral Mydriasis Versus Topical Mydriasis in Cataract Surgery

Start date: March 2008
Phase: N/A
Study type: Interventional

The purpose is to determine if an intracameral solution of 0.2% tropicamide and 2% phenylephrine can dilate the pupil for cataract surgery as well as pre-operative topical 1% tropicamide and 5% phenylephrine. We will be looking at two separate groups of patients, those with and those without pseudoexfoliation syndrome. We will be looking at how each method affects the size of the pupil at the beginning and at the end of cataract surgery. In addittion, we will look at what effect the two different methods have on blood pressure and heart rate in the pre-operative, peri-operative and post-operative periods.

NCT ID: NCT00687791 Recruiting - Cataract Clinical Trials

Oculusgen (Ologen) Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: A Case-Control Study

Start date: December 2007
Phase: Phase 3
Study type: Interventional

The objective of this study is to determine the safety and effectiveness of the OculusGen™ (ologen) Biodegradable Collagen Matrix Implant in hacotrabeculectomy surgery. The primary endpoint is to prove the effectiveness via the reduction of IOP, and the secondary endpoint is to prove the safety via the incidence of complications and adverse events.

NCT ID: NCT00684138 Completed - Cataract Clinical Trials

ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power Intraocular Lens (IOL)

Start date: June 2007
Phase: Phase 4
Study type: Interventional

Randomized, parallel group, subject masked, multi-center six (6) month follow-up study comparing ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power IOL Model SN6AD1 implanted in both eyes to ACRYSOF® ReSTOR® Aspheric +4.0 D Add Power IOL Model SN6AD3 implanted in both eyes.

NCT ID: NCT00673803 Completed - Cataract Clinical Trials

Influence of Two Different Preloaded Intraocular Lens (IOLs) on Posterior Capsule Opacification

Start date: December 2008
Phase: Phase 4
Study type: Interventional

Studies showed that a sharp posterior optic edge of an intraocular lens (IOL) inhibits migration of lens epithelial cells in between posterior capsule and optic of the IOL and therefore reduces the rate of posterior capsule opacification (PCO). In present time most IOLs implanted have a sharp posterior optic edge. Due to differences in IOL production different IOLs have different rates of PCO. Progression in cataract surgery technique allow phacoemulsification through micro-incisions. Therefore there is need for IOLs that can be implanted through incisions of about 2.5 mm. This study investigates the effect of two different hydrophobic acrylic IOLs with a sharp posterior optic edge on the rate of PCO after implantation through a micro-incision. The results will be compared intraindividually.

NCT ID: NCT00666042 Completed - Cataract Clinical Trials

Bioequivalence of Eye Drops and Spray Administration of Vigamox

Start date: February 2009
Phase: N/A
Study type: Interventional

The study compares the amounts of Vigamox absorbed when administered as eye drops or in a spray form. Both administrations will be prior to patients undergoing elective cataract surgery and the aqueous samples will be analyzed by a laboratory in a masked fashion. The hypothesis is that there will be no difference between the 2 modes of administration.

NCT ID: NCT00630019 Completed - Cataract Clinical Trials

Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator

Start date: February 2008
Phase: Phase 4
Study type: Interventional

Compare ocular tissue levels following topical ocular instillation of 1.5% levofloxacin ophthalmic solution or an active comparator in subjects undergoing cataract surgery.

NCT ID: NCT00624039 Enrolling by invitation - Cataract Clinical Trials

The Effect of Cataract Extraction on the Contractility of Ciliary Muscle

Start date: May 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the changes in the pilocarpine-induced ciliary body movement before and after cataract extraction in order to determine the effect of lens sclerosis on the ciliary muscle contractility.

NCT ID: NCT00621933 Completed - Cataract Clinical Trials

Surveillance of Ocular Surface Flora (SURFACE)

Start date: December 2007
Phase:
Study type: Observational

Topical fluoroquinolones (FQs) have achieved widespread use in ophthalmology for both the treatment and prophylaxis of ocular infections. The present study is set to determine the bacteria present on the ocular surface in patients at the time of cataract surgery and to assess the rate of resistance of ocular isolates to commonly used topical antibiotics.